The impact of U.S. policies to protect healthcare workers from bloodborne pathogens: The critical role of safety-engineered devices

Journal of Infection and Public Health

Volumn 1, Issue 2, 2008, Pages 62-71

  Jagger, Janine ^a   Perry, Jane ^a   Gomaa, Ahmed ^b   Phillips, Elayne Kornblatt ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Bloodborne pathogens regulations; Healthcare worker safety; Needlestick injuries sharps injuries; Occupational exposures; Safety engineered sharp devices

Indexed keywords

DEVICE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LAW; NEEDLESTICK INJURY; NURSE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; UNITED STATES;

BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HEALTH PERSONNEL; HEALTH POLICY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEEDLESTICK INJURIES; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINES AS TOPIC; PROTECTIVE DEVICES; SAFETY MANAGEMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; UNITED STATES OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION;

EID: 63549115170     PISSN: 18760341     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jiph.2008.10.002     Document Type: Review

References (46)

1. Anon. Needlestick transmission of HTLV-III from a patient infected in Africa [editorial]. Lancet 1984;2:1376-77.
2. U.S. Centers for Disease Control and Prevention. Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR Morb Mortal Wkly Rep 36 (1987) 285-289
3. U.S. Centers for Disease Control and Prevention. Recommendation for prevention of HIV transmission in health-care settings. MMWR 36 Suppl. 2 (1987) 1-18
4. U.S. Department of Labor and Department of Health and Human Services. Joint advisory notice: protection against occupational exposure to hepatitis B (HBV) and human immunodeficiency virus (HIV). 52 Fed Regist 41.818; October 19, 1987. Available at: http://www.cdc.gov/niosh/hcwapp5.html. Accessed 10/2/08.
5. U.S. Department of Labor, Occupational Safety and Health Administration. Advance notice of proposed rulemaking pertaining to occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Fed Regist 52 November 27 (1987) 45438-45441
6. U.S. Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens. Final rule. Fed Regist 56 235 (1991) 64004-64182
7. Mahoney F.J., Stewart K., Hu H., Coleman P., and Alter M.J. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 157 (1997) 2601-2605
8. Cardo D.M., Culver D.H., Ciesielski C.A., Srivastava P.U., Marcus R., Abiteboul D., et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 337 (1997) 1485-1490
9. U.S. Centers for Disease Control and Prevention. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 47 No. RR-7 (1998) 1-34
10. Do A.N., Ciesielski C.A., Metler R.P., Hammett T.A., Li J., and Fleming P.L. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 24 (2003) 86-96
11. Jagger J., De Carli G., Perry J., Puro V., and Ippolito G. Occupational exposure to bloodborne pathogens: epidemiology and prevention. In: Wenzel R.P. (Ed). Prevention and control of nosocomial infections (2003), Lippincott Williams & Wilkins 437
12. Centers for Disease Control and Prevention. Web page: surveillance of healthcare personnel with HIV/AIDS, as of December 2002. Table: Healthcare personnel with documented and possible occupationally acquired AIDS/HIV infection, by occupation, as of December 2002. Available at: http://www.cdc.gov/ncidod/dhqp/bp_hiv_hp_with.html. Accessed 10/02/08.
13. Jagger J., and Bentley M. Disposal-related sharp-object injuries. Adv Expo Prev 1 5 (1995) p. 1-2, 6-7, 11
14. Kelly D. Trends in U.S. patents for needlestick prevention technology. Adv Expo Prev 2 4 (1996) 7-8
15. U.S. Food and Drug Administration. Safety alert: needlestick and other risks from hypodermic needles on secondary I.V. administration sets-piggyback and intermittent I.V. April 16, 1992 (1992), Department of Health and Human Services, Rockville, MD
16. Jagger J., and Perry J. Comparison of EPINet data for 1993 and 2001 shows marked decline in needlestick injury rates. Adv Expo Prev 6 3 (2003) 25-27
17. U.S. Food and Drug Administration (in conjuction with the National Institute for Occupational Safety and Health and the Occupational Safety and Health Administration). Glass capillary tubes: joint safety advisory about potential risks. Rockville, MD; February 1999.
18. International Healthcare Worker Safety Center, University of Virginia. U.S. EPINet Multihospital Sharps Injury Surveillance Network. Needlestick and Sharp-Object Reports for January 1, 1994-December 31, 1998 (5 years of data; total injuries = 15,389; total number of hospitals reporting injuries = 76), and January 1, 2000-December 31, 2004 (5 years of data; total number of injuries = 7941; total number of hospitals reporting injuries = 66). Reports available upon request.
19. Billiet L.S., Parker C.R., Tanley P.C., and Wallas C.H. Needlestick injury rate reduction during phlebotomy: a comparative study of two safety devices. Lab Med 22 (1991) 120-123
20. Orenstein R., Reynolds L., Karabaic M., Lamb A., Markowitz S.M., and Wong E.S. Do protective devices prevent needlestick injuries among health care workers?. Am J Infect Control 23 (1995) 344-351
21. O'Connor R.E., Krall S.P., Megargel R.E., Tan L.E., and Bouzoukis J.K. Reducing the rate of paramedic needlesticks in emergency medical services: the role of self-capping intravenous catheters. Acad Emerg Med 3 (1996) 668-674
22. Jagger J., and Bentley M.B. Injuries from vascular access devices: high risk and preventable. Collaborative EPINet Surveillance Group. J Intraven Nurs 20 6, Suppl. (1997) S33-S39
23. U.S. Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures-Minneapolis, St. Paul, New York City, and San Francisco, 1993-1995. MMWR Morb Mortal Wkly Rep 46 (1997) 21-23
24. U.S. Centers for Disease Control and Prevention. Evaluation of blunt suture needles in preventing percutaneous injuries among health-care workers during gynecologic surgical procedures-New York City, March 1993-June 1994. J Am Med Assoc 277 (1997) 451-452
25. Duesman K., and Ross J. Survey of accidental needlesticks in 26 facilities using Vanishpoint automated retraction syringe. J Healthcare Saf Compliance Infect Control 2 (1998) 111-114
26. Roudot-Thoraval F., Montagne O., Schaeffer A., Dubreuil-Lemaire M.L., Hachard D., and Durand-Zaleski I. Costs and benefits of measures to prevent needlestick injuries in a university hospital. Infect Control Hosp Epidemiol 20 9 (1999) 614-617
27. Mendelson M.H., Chen L.B.Y., Finkelstein L.E., Bailey E., and Kogan G. Evaluation of a safety IV catheter (Insyte Autoguard, Becton Dickinson) using the Centers for Disease Control and Prevention (CDC) National Surveillance System for Hospital Healthcare Workers database. Infect Control Hosp Epidemiol 21 (2000) 111
28. Chen L.B.Y., Bailey E., Kogan G., Finkelstein L.E., and Mendelson M.H. Prevention of needlestick injuries in healthcare workers: 27 month experience with a resheathable safety winged steel needle using CDC NaSH Database. Infect Control Hosp Epidemiol 21 (2000) 108
29. Perry J. California leads the way with healthcare worker safety law. Adv Expo Prev 4 1 (1998) p. 1, 4-5
30. Perry J. The push towards safety: manufacturers respond to changes in regulatory and legislative climate. Adv Expo Prev 5 1 (2000) 5-6
31. Pugliese G., and Perry J. The Needlestick Safety and Prevention Act (H.R. 5178): what does it require?. Adv Expo Prev 5 4 (2000) p. 41-42, 46
32. U.S. Occupational Safety and Health Administration. Record summary of the request for information on occupational exposure to bloodborne pathogens due to percutaneous injury; May 20, 1999. Available at: http://www.osha.gov/html/ndlreport052099.html. Accessed 10/02/08.
33. U.S. General Accounting Office. Occupational safety: selected cost and benefit implications of needlestick prevention devices for hospitals. Washington, DC: GAO-01-60R; November 17, 2000.
34. U.S. Occupational Safety and Health Administration. OSHA Instruction: enforcement procedures for the occupational exposure to bloodborne pathogens. Directive number CPL2-2.44D (November 5, 1999), Department of Labor, Washington, DC
35. Needlestick Safety and Prevention Act of 2000. Publication No. 106-430, 114 Stat. 1901; November 6, 2000.
36. U.S. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries; final rule. 29 CFR Part 1910. Supplementary information; Part III: Summary and explanation. Fed Regist 2001;66(12):5318-25. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=16265&p_table=FEDERAL_REGISTER. Accessed 10/02/08.
37. U.S. Occupational Safety and Health Administration. OSHA Instruction: Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive number CPL2-2.69. Washington DC: Department of Labor; November 27, 2001. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=DIRECTIVES&p_id=2570. Accessed 10/02/08.
38. U.S. Occupational Safety and Health Administration. Standard Interpretations: 11/26/2001-response to the American Academy of Pediatrics regarding the Needlestick Safety and Prevention Act. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=24003. Accessed 10/02/08.
39. U.S. Occupational Safety and Health Administration. Standard Interpretations: 11/21/2002-safer medical devices must be selected based on employee feedback and device effectiveness, not Group Purchasing Organizations. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=24385&p_text_version=FALSE. Accessed 10/2/08.
40. Hogan A. Gaps and successes of safety device market conversion. Mater Manag Health Care 14 11 (2005) 33-34
41. Jagger J. Estimated incremental hospital cost of safety features by device type for needles most often associated with healthcare worker HIV seroconversions [table]. In: Jagger J, Perry J, editors. Preventing occupational exposures to bloodborne pathogens: articles from Advances in Exposure Prevention, 1994-2003. Charlottesville, VA: International Healthcare Worker Safety Center; 2004. p. 192.
42. Sohn S., Eagan J., Sepkowitz K.A., and Zuccotti G. Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol 25 (2004) 536-542
43. Perry J.L., Pearson R.D., and Jagger J. Infected healthcare workers and patient safety: a double standard. Am J Infect Control 34 (2006) 314-319
44. Perry J. Conventional sharp devices: a dying breed?. Outpatient Surg Mag 4 6 (2003) 70
45. Bureau of Labor Statistics, U.S. Department of Labor. Career guide to industries (2008-2009 edition): health care. Table 3: employment in health care by industry segment (2006 and projected change, 2006-2016). Available at: http://www.bls.gov/oco/cg/cgs035.htm. Accessed October 2, 2008.
46. American College of Surgeons, Committee on Perioperative Care. Statement on sharps safety. Bull Am Coll Surg 92 October (10) (2007) 34-37